King County Navigation Bar (text navigation at bottom)
Public Health - Seattle & King County
Site Directory

Public Health Webpage Directory

Public Health Center & Office Locations

For Care Providers

Health Care Providers homepage

For Educators

Health Educators Toolbox

About Us

History & Profile

Jobs

Employee Directory

Contact Us

Public Health
Seattle & King County
401 5th Ave., Suite 1300
Seattle, WA 98104

Phone: 206-296-4600
TTY Relay: 711

Click here to email us

Subscribe to Free Email Alerts!

Click here to learn more

magnifying glass Advanced Search
Search Tips
Home » Health Care Providers » Epidemiology » HCV

Information Health Advisories & Resources
Reporting Hepatitis C Virus (HCV) Infection

Chronic hepatitis C virus (HCV) infection is now reportable by health care providers and institutions (not laboratories) in order to define the prevalence of disease locally, and to provide data necessary to obtain and allocate resources for HCV prevention activities. Public Health will classify cases as confirmed, probable or possible based on the following criteria.

A confirmed case of chronic HCV infection is defined as a case that has tested positive for HCV by anti-HCV enzyme immunoassay (EIA) plus supplemental confirmatory testing by recombinant immunoblot assay (RIBA) or any case with positive qualitative or quantitative HCV RNA testing. Because EIA testing has an unacceptably high false-positive rate (30-50%) when testing persons at low to moderate risk, a positive EIA without confirmatory testing is currently not considered diagnostic of HCV infection by the Centers for Disease Control and Prevention (CDC). HCV RNA may be undetectable in persons who are undergoing antiviral treatment for hepatitis C or who have spontaneously cleared the infection. In these cases, RIBA testing is the preferred confirmatory test. Persons reported to be positive for HCV by blood banks have had confirmatory testing (RIBA, and for all RIBA-positive tests, HCV RNA).

A probable case is defined as a positive HCV EIA test result in the absence of confirmatory testing in persons at high risk for HCV infection including persons who a) have ever used injection drugs, b) have received blood factor concentrates prior to 1987, and c) have persistently elevated liver enzymes with no other explanation. In these settings, a positive EIA result alone is likely to represent infection, therefore it is especially important to obtain and report risk factor information for all EIA-positive cases that do not have confirmatory testing.

Cases with a positive HCV EIA test and not meeting the "confirmed" or "probable" case definitions will be classified as possible HCV cases. Clinicians are encouraged to obtain confirmatory testing before establishing the diagnosis of chronic HCV infection.

Whenever possible please provide the following information when reporting a case of chronic HCV infection: routine demographic data, results and dates of diagnostic tests for HCV including results of confirmatory testing and liver function tests, and patient risk factor information. To order communicable disease case report forms please call 206-296-4774. Click here to see a complete list of information needed to enter a case.

Risk factors of relevance include: ever using injection drugs, receiving blood products or an organ transplant prior to July, 1992, receiving factor concentrates before 1987, receiving hemodialysis, sustaining a occupational needlestick or blood splash, history of ever being a sexual partner of someone else who has been diagnosed as a hepatitis C carrier, or being an infant born to a mother who is a hepatitis C carrier.

Confirmed and probable cases of chronic hepatitis C are reportable by health care providers within one month from initial diagnosis or one month from follow up testing of chronic HCV carriers. If you are uncertain whether a case has already been reported, please proceed with reporting.

The Centers for Disease Control and Prevention's web site has a good clinical education program that offers CME credit and includes additional information on hepatitis C diagnostic testing at: www.cdc.gov/ncidod/diseases/hepatitis/C_Training/edu/default.htm.

For additional questions about hepatitis C reporting, contact Sandra Randels, 206-296-4774. For contact information for Communicable Disease Control for case reporting, click here.

Information needed to enter a case

Whenever possible, the following information should be included in your initial report of confirmed or suspected cases of viral hepatitis:

1.

Case demographic information: name, birthdate, address, telephone number, race and gender.

2.

Laboratory results: date blood drawn, results of all hepatitis markers and liver function tests, if done, not just abnormal results.

3.

Clinical information: reason for testing, clinical symptoms and date of onset of hepatitis, whether the case is a known HCV "carrier".

4.

Health care provider's information: name, address, and telephone number.


Contact information for case reporting

Reporting of hepatitis and other notifiable conditions to Communicable Disease Control and Epidemiology can be done by:

1.

calling 206-296-4774 between 8 am - 5pm

2.

calling our 24-hour report line at 206-296-4782

3.

faxing a copy of the test results along with case report information to our confidential fax at 206-296-4803, or for chronic cases only, mailing a copy of the test results to our office.

Updated: Tuesday, June 08, 2004 at 12:15 PM

All information is general in nature and is not intended to be used as a substitute for appropriate professional advice. For more information please call 206-296-4600 (voice) or 206-296-4631 (TTY Relay service). Mailing address: ATTN: Communications Team, Public Health - Seattle & King County, 401 5th Ave., Suite 1300, Seattle, WA 98104 or click here to email us.

King County | Public Health | News | Services | Comments | Search

Links to external sites do not constitute endorsements by King County.
By visiting this and other King County web pages, you expressly agree to be bound by terms
and conditions of the site. The details.